|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 512 10TH STREET NW |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 28481-12
|
||||||||
|
6. House ID# 316440000
|
TYPE OF REPORT | 8. Year | 2014 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Douglas Johnson, Legislative Director |
Date | 01/19/2015 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Contacts in support of pro-life provisions in FY 2015 appropriations bills are reported on the FAM (Family Issues/Abortion/Adoption) pages.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DOC
16. Specific lobbying issues
Contacts in support of laws to protect unborn children within the Federal District, including contacts in support of preservation of the "D.C. Hyde Amendment," a prohibition on the use of any congressionally appropriated funds for abortions (with certain exceptions) in the District of Columbia, in FY 2015 financial services and general government appropriations bills (H.R.5016) and FY 2015 omnibus appropriations billl (H.R. 83, Public Law 113-235. (continued)
Contacts in opposition to all ongoing efforts to weaken congressional control over spending by the local administrative government of the Federal District, including District Council initiative to institute illegal expenditures of funds without congressional appropriation, in violation of the federal Anti-Deficiency Act and other federal laws, and contacts in opposition to any proposed legislation to relax legal prohibitions on such action without sufficient safeguards.
Contacts in opposition to proposal pending before the Council of the District of Columbia that would prohibit pro-life organization from maintaining pro-life employment policies ("Reproductive Health Non-discrimination Amendment Act").
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
Contacts in support of No Taxpayer Funding for Abortion Act (H.R. 7, S. 946), to codify government-wide policy against funding abortion. Contacts in support of Abortion Insurance Full Disclosure Act (H.R. 3279, S. 1848), legislation to correct concealment practices pertaining to abortion coverage in exchange-participating health plans. (continued)
Contacts in support of the Pain-Capable Unborn Child Protection Act, to protect pain-capable unborn children beginning at 20 weeks fetal age (S. 1670).
Contacts in support of Prenatal Nondiscrimination Act (PRENDA), to ban sex-selection abortions (S. 138, HR 447).
Contacts in support of Child Interstate Abortion Notification Act (CIANA)(S. 369, HR 732), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions.
Contacts in support of the Health Care Conscience Rights Act (HR 940, S. 1204), to prevent the imposition of regulatory mandates that violate the religious or moral convictions of those who purchase or provide health insurance, to prevent any level of government from discriminating against health care providers who decline to participate in abortions, and to empower victims to seek relief in court for violations of the federal conscience laws. Contacts in opposition to the "Protect Women's Health from Corporate Interference Act" (S. 2578/H.R. 5051), legislation which would further empower the Obama Administration to mandate that certain insurance plans cover abortion pills such as RU-486, surgical abortion (including late abortions), assisted suicide, or anything else the Administration chooses to classify as preventive services, overriding all existing federal laws that protect religious freedom and conscience rights; the Senate refused to invoke cloture to proceed to this legislation on July 16, 2014. Contacts in support of possible inclusion of abortion non-discrimination language in FY 2015 omibus appropriations legislation (not included), H.R. 83 (became Public Law 113-235).
Contacts in support of carrying over abortion-related limitation provisions in FY 2015 appropriations bills, including Hyde Amendment in HHS appropriations bill, and other abortion limitation provisions in Commerce-Justice-Science (H.R. 4660/S. 2437), Financial Services (H.R. 5016), and State-Foreign Operations (H.R. 5013/S. 2499) appropriations bills; no position on State-Foreign Operations provision conforming language related to the Peace Corps to comparable HHS language. Contacts in support of continuation of abortion-related limitation provisions in omnibus appropriations measure, H.R. 83 (became Public Law 113-235). Contacts in support of curtailing U.S. funding of UNFPA. Contacts in opposition to language proposed by Sen. Shaheen to State/Foreign Operations appropriations bill (S. 2499) to preclude a president from re-applying pro-life conditions to private organizations that receive foreign aid grants (e.g., "Mexico City Policy"), as adopted in Senate Appropriations Committee June 19, 2014.
Contacts in support of the Homeland Security Respect for Life Act (H.R. 493), to prevent federal funding of abortion under programs within the Department of Homeland Security, with certain exceptions, and comparable limitation language ("Aderholt-Carter Amendment") to FY 2015 Homeland Security appropriations bill (H.R. 4903).
Contacts in support of S. 154/HR 346, to prevent coverage of abortion, with certain exceptions, in "multi-state" (national) health plans, created by PL 111-148, to be administered by the Office of Personnel Management, and comparable language ("Harris-Nunnelee Amendment"), added to FY 2015 Financial Services appropriations bill (H.R. 5016) at House Appropriation Committee markup, June 25, 2014, 29-21. H.R. 5016 passed the House July 16, 2014, without challenge to this provision.
Contacts in support of the Title X Abortion Provider Prohibition Act (HR 217/S. 135).
(continued)
Contacts in support of H.R. 4698, the Every Child is a Blessing Act (legislation to curb use of wrongful birth and wrongful life causes of action), introduced by Rep. Palazzo on May 21, 2014.
Consultations regarding anti-trafficking legislation, H.R. 3530; no position taken on substitute as reported by the House Judiciary Committee on May 15, 2014, and approved by the House on May 20, 2014. Contacts in support of adding language to parallel Senate proposals, to prevent funding of abortion, including potential amendments to S. 2646 or S. 2599.
Contacts in opposition to "Women's Health Protection Act" (H.R. 3471, S. 1696), a proposed federal statute to invalidate virtually all state and federal regulations pertaining to abortion.
Contacts explaining nonsupport for H.R. 1091/S. 583 and H.R. 2764, based on lack of clarity and erroneous legal premises.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
See abortion-related policy issues reported under FAM (Family Issues/Abortion/Adoption).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
U.S. HOUSE OF REPRESENTATIVES
Contacts in support of repealing the Patient Protection and Affordable Care Act, Public Law 111-148, because repeal would (continued)
1) eliminate the excise tax on high cost employer-sponsored health coverage which would discourage businesses from offering plans less likely to deny life-saving medical treatment, 2) eliminate the Independent Payment Advisory Boards duty to make recommendations to limit growth in private, nongovernmental spending on health to below the rate of medical inflation, 3) eliminate the authority of the Department of Health and Human Services to implement those recommendations by imposing quality and efficiency measures on health care providers, limiting the circumstances in which treatments can be given to their patients, 4) eliminate the authority of the Center for Medicare and Medicaid Services effectively to limit the amount of funds senior citizens may voluntarily add on top of the government contribution in order to obtain Medicare Advantage private-fee-for-service health insurance less likely to deny care and more likely to offer health care providers reimbursement rates high enough to induce them to accept Medicare patients, 5) eliminate the requirement that state health insurance exchanges administrators exclude from their exchanges insurance plans offered by any insurers the administrators believe allow their policyholders inside or outside the exchange to spend what the administrators consider an excessive or unjustified amount on their own health care, thereby restricting the medical treatment, and 6) eliminate the provisions related to shared decisionmaking because they are likely to be used, on balance, to dissuade patients from choosing life-saving treatment.
Contacts in response to inquiries regarding implementation of certain elements of The Patient Protection and Affordable Care Act, Public Law 111-148, related to the denial of life-saving medical treatments.
Contacts regarding H.R. 1173, the Personalize Your Care Act of 2013, because 1) it provides for inadequate oversight regarding the creation of advance planning materials, websites, etc. in order to protect against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, 2) unmonitored practitioner consultations could lead to patients forgoing treatment they would otherwise have wanted, and 3) it includes adverse changes to the Assisted Suicide Funding and Restriction Act.
Contacts in regard to potential health reform legislation (not introduced) over concerns related to 1) the authority of any sort of health care commissions ability to restrict access to life-saving care, 2) premium price controls that might reduce the ability of insurance to cover life-saving care, 3) tax increases on health care or health insurance that create incentives for employers to significantly reduce health insurance plans, 4) efforts to prevent private health care spending from keeping up with medical inflation, and 5) malpractice limits being made applicable to intentional denial of treatment for discriminatory reasons.
Contacts regarding legislation (not introduced), the Medicare Choices Empowerment and Protection Act, regarding advance directives to ensure that legislation is not used to dissuade patients from choosing life-saving treatment, nutrition and hydration.
Contacts regarding legislation (not introduced) regarding advance planning to ensure process of explaining, discussing, completing, or assisting in completing an advance directive is not used to dissuade patients from choosing life-saving treatment, nutrition and hydration.
(continued)
U.S. SENATE
Contacts in support of repealing The Patient Protection and Affordable Care Act, Public Law 111-148, because repeal would 1) eliminate the excise tax on high cost employer-sponsored health coverage which would discourage businesses from offering plans less likely to deny life-saving medical treatment, 2) eliminate the Independent Payment Advisory Boards duty to make recommendations to limit growth in private, nongovernmental spending on health to below the rate of medical inflation, 3) eliminate the authority of the Department of Health and Human Services to implement those recommendations by imposing quality and efficiency measures on health care providers, limiting the circumstances in which treatments can be given to their patients, 4) eliminate the authority of the Center for Medicare and Medicaid Services effectively to limit the amount of funds senior citizens may voluntarily add on top of the government contribution in order to obtain Medicare Advantage private-fee-for-service health insurance less likely to deny care and more likely to offer health care providers reimbursement rates high enough to induce them to accept Medicare patients, 5) eliminate the requirement that state health insurance exchanges administrators exclude from their exchanges insurance plans offered by any insurers the administrators believe allow their policyholders inside or outside the exchange to spend what the administrators consider an excessive or unjustified amount on their own health care, thereby restricting the medical treatment, and 6) eliminate the provisions related to shared decisionmaking because they are likely to be used, on balance, to dissuade patients from choosing life-saving treatment.
Contacts in response to inquiries regarding implementation of certain elements of The Patient Protection and Affordable Care Act, Public Law 111-148, related to the denial of life-saving medical treatments.
Contacts in support of S. 2064, the Repeal Rationing in Support of Life Act of 2014, because it would 1) eliminate the Independent Payment Advisory Boards duty to make recommendations to limit growth in private, nongovernmental spending on health to below the rate of medical inflation, 2) eliminate the excise tax on high cost employer-sponsored health coverage which would discourage businesses from offering plans less likely to deny life-saving medical treatment, 3) eliminate the authority of the Department of Health and Human Services to implement those recommendations by imposing quality and efficiency measures on health care providers, limiting the circumstances in which treatments can be given to their patients, 4) eliminate the authority of the Center for Medicare and Medicaid Services effectively to limit the amount of funds senior citizens may voluntarily add on top of the government contribution in order to obtain Medicare Advantage private-fee-for-service health insurance less likely to deny care and more likely to offer health care providers reimbursement rates high enough to induce them to accept Medicare patients, 5) eliminate the requirement that state health insurance exchanges administrators exclude from their exchanges insurance plans offered by any insurers the administrators believe allow their policyholders inside or outside the exchange to spend what the administrators consider an excessive or unjustified amount on their own health care, thereby restricting the medical treatment.
(continued)
Contacts regarding legislation (not introduced) regarding encouraging advance directives for Medicare recipients so long as legislation is not used to dissuade patients from choosing life-saving treatment, nutrition and hydration.
Contacts regarding legislation S.1439, the Care Planning Act of 2013, regarding advance care planning because of 1) the inadequacy of oversight regarding the creation of advance planning materials, websites, etc. in order to protection against the materials being crafted in a way that persuades patients to reject treatment they might otherwise choose, and 2) the creation of interdisciplinary teams under Medicare and Medicaid to engage in advance care planning and counseling without adequate oversight that they could seek influence patients or their representative to forego life-saving medical treatment because of a bias toward a quality of life ideology and/or to save money.
Contacts regarding legislation S.2240 Medicare Choices Empowerment and Protection Act because of 1) the need for a neutral website where all the various advance directive forms would be available and 2) the potential that portability provisions could force states to recognize directives inconsistent with their substantive law.
Contacts in regard to potential health reform legislation (not introduced) over concerns related to 1) the authority of any sort of health care commissions ability to restrict access to life-saving care, 2) premium price controls that might reduce the ability of insurance to cover expensive life-saving care, 3) tax increases on health care or health insurance that create incentives for employers to significantly reduce health insurance plans, 4) efforts to prevent private health care spending from keeping up with medical inflation, and 5) malpractice limits being made applicable to intentional denial of treatment for discriminatory reasons.
Contacts regarding legislation (not introduced) regarding advance directives to ensure that legislation is not used to dissuade patients from choosing life-saving treatment, nutrition and hydration.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Thomas (Burke) |
Balch |
|
|
|
Jennifer |
Popik |
|
|
|
Susan |
Muskett |
|
|
|
Douglas |
Johnson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Thomas (Burke) |
Balch |
|
|
|
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Abortion-related policy issues are reported under FAM (Family Issues/Abortion/Adoption). Issues related to health care rationing are reported under HCR (Health Issues).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
|
Thomas (Burke) |
Balch |
|
|
|
Jennifer |
Popik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
Contacts in support of Human Cloning Prohibition Act (H.R. 2164), to prohibit creation of human embryos by cloning. Contacts in opposition to "Stem Cell Research Advancement Act" (H.R. 2433), legislation to authorize federal funding of research that kills human embryos, including research involving the creation of human embryos by cloning for purposes of use in research that will kill them ("clone and kill").
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Douglas |
Johnson |
|
|
|
Susan |
Muskett |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
CON |
|
|
|
|
|
|
|
|
GOV |
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |